Navigation Links
PatchMan - Test Report

The new Ependorf Micromanipulator for electro-physiology, PatchMan, was tested under practical conditions at the Max-Planck-Institute (MPI) for Biophysical Chemistry in Gttingen (Germany). Eppendorf received the following report:
The Micromanipulator PatchMan was used at MPI for a variety of patch clamp experiments:
We performed whole cell experiments on chromaffine cells and RBL cells. Chromaffine cells have a diameter of 510 m. Exact, fine positioning is thus absolutely necessary to produce a giga seal. Measurements were performed over 530 minutes. It is very important that the measurements were drift-free.

Patch clamp experiment on a chromaffine cell from the suprarenal suture We performed 2030 single experiments per day. Each of these experiments included the mounting of a pipette into the pipette holder, subsequent lowering into the experimenting chamber with the HOME function and the positioning of the pipette (diameter of opening: 1 m) on the cell using the joystick.

On the whole, the pipette was positioned in the SLOW mode. However, we also tested the STEP mode. At the end of measurement, the pipette was returned to the HOME position to facilitate its exchange for the next experiment.

Results
  1. The PatchMan works well. Its range of functions, two variable speeds, and CLEAN/HOME function are completely sufficient for at least 90% of all standard patch clamp experiments. The STEP mode is only interesting fo r beginners as even very fine movements can be performed with the joystick in the SLOW mode after only a little practice. Axial movement was not used in the experiments performed.
  2. Operation is very easy and the functional controls are good. Users of the Micromanipulator 5171 found that operation with 4 buttons was easier.
  3. Travel behavior is excellent. Movements are smooth and easy to control. The joystick works well and has just the right spring-loading (almost better than for MM 5171). The resistance is a little larger and the user has the impression that he has better control.
  4. No electrical interference was determined in the range checked (up to 5 kHz).
  5. No drift was determined during the period measured (* 30 minutes). Therefore, PatchMan can be considered to be absolutely drift-free for patch clamp measurements.
  6. The optional CLEAN function is only useful for specific patch clamp users. It should not be activated at the factory.

    On the whole, PatchMan made a very good impression on the scientists at the MPI for Biophysical Chemistry. It provides a very good alternative to the Micromanipulator 5171 for general patch clamp measurements.

    This concludes the report from the MPI in Gttingen.

'"/>

Source:


Page: All 1 2

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
3. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
4. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
5. Versatile Reporter Vectors for Monitoring Viral Transduction
6. In Vivo Signal Transduction Pathway Reporting Systems
7. Improved Vectors for PathDetect Trans-Reporting Systems
8. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
9. Cis-Reporting System Monitors Intracellular Calcium Mobilization
10. Cis-Reporting System Monitors Intracellular Calcium Mobilization
11. Genetic Reporter Systems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):